Progyny (PGNY) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Progyny (PGNY) is Neutral.

The composite score behind that read is +0.06, weighing +0.21 of bullish evidence against -0.19 bearish.

Progyny last closed at $27.93, +0.36% on the session.

Against the IVW growth benchmark the position is -0.44% over the forecast window.

The read is built from 15 underlying insights — 6 bullish and 9 bearish.

Agreement across those insights is 60%.

Progyny has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Progyny in the 28th percentile on valuation and the 74th percentile on return on equity, where 100 is best.

Progyny is classified under Health Care / Health Care Providers & Services, with a market capitalisation of $2.14B.

StockMap tracks Progyny as the 40th largest of the 85 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 81 Neutral and 4 Moderate Underperform.

On that composite Progyny ranks 24th of 85 in the group, against a group median of +0.00.